Federal Policy Shift: Overview of the โTreatment Firstโ Homelessness Toolkit and Clinical Perspectives Executive Summary Federal health officials have introduced a new framework entitled “Treatment First,” signaling a strategic policy …
-
Buprenorphine Dispensing Declined After 2021 Despite Gains in Access and Emergency Department Use August 31, 2026 Key Points Pharmacy dispensing of buprenorphine increased from 2019 through 2021 but declined from …
-
Study Finds No Association Between Circumcision and Autism Key Points In an analysis of 2,771 boys enrolled in the NIH Environmental Influences on Child Health Outcomes (ECHO) cohort, circumcision was …
-
Ophthalmologists Show Highest Accuracy for Thyroid Eye Disease Referrals September 14, 2026 A retrospective study presented at the Women in Ophthalmology Summer Symposium found that ophthalmologists had the highest accuracy …
-
Higher Circulating Xylitol Levels Associated With Increased Cardiovascular Event Risk in 2 Prospective Cohorts September 22, 2026 Key Points Higher circulating concentrations of xylitol were associated with an increased risk …
-
Association Between Invasive Cancer Diagnosis and Short-Term Risk of First-Ever Ischemic Stroke: A Nationwide Cohort Study Background and Epidemiologic Context Malignancy and cerebrovascular disease constitute two leading global contributors to …
-
Association of Nirsevimab Administration With Downstream Reductions in Infant Antibiotic Prescribing Background and Study Rationale Immunization with the long-acting monoclonal antibody nirsevimab (Beyfortus) significantly reduces outpatient and inpatient antibiotic prescribing …
Gestational Diabetes Associated With Earlier Onset of Type 2 Diabetes in Later Life September 22, 2026 Key Points Study Overview Women who develop gestational diabetes during pregnancy may face not …
FDA Grants Breakthrough Therapy Designation to DT120 ODT for Major Depressive Disorder: Phase 3 Evidence Highlights Rapid and Durable Antidepressant Effects Abstract The U.S. Food and Drug Administration (FDA) has …
FDA Accepts Investigational New Drug Application for OX640 Intranasal Epinephrine Powder in Anaphylaxis Regulatory Milestone and Clinical Background The US Food and Drug Administration (FDA) has accepted an Investigational New …